echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New method to save the heart muscle, minimally invasive can "repair" the heart

    New method to save the heart muscle, minimally invasive can "repair" the heart

    • Last Update: 2021-03-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Professor Cheng Ke’s team researched and reported a new method of minimally invasive “injection” of heart patches.

    Heart disease seriously threatens the lives of patients.


    Existing methods such as intravenous injection, coronary artery injection, myocardial injection, and myocardial patch are used to deliver stem cells to treat damaged myocardium.


    The team of Professor Cheng Ke from North Carolina State University and the University of North Carolina at Chapel Hill reported on a new method of minimally invasive "injection" of heart patches.


    This method injects a hydrogel carrying stem cells or exosomes into the pericardial cavity, and uses the pericardial cavity as a natural hydrogel shaping "mold" to form a uniform repair patch on the surface of the heart.


    Cell and exosomal treatments provide promising regenerative medicine solutions for repairing damaged myocardium.


    How to directly deliver these therapeutics to the injured area and improve the delivery efficiency is an important challenge for stem cells and exosomes to treat cardiomyopathy.


    "The heart patch is an effective method, but the implantation of the heart patch generally requires open thoracic surgery, and the trauma is serious.


    We seek a safe and effective method that can be implemented minimally.


    The pericardial cavity is a space between the pericardium and the heart, which is filled with pericardial fluid to provide protection and lubrication for the heart.


    Using the pericardial cavity as a natural mold, using hydrogel to load stem cells and exosomes, through intrapericardial injection, the research team successfully implanted a "heart patch" in the area of ​​myocardial infarction, achieving an "in-situ" mold .


    "We call this delivery method intraPeriCardial injection, that is, iPC injection," Professor Cheng Ke said.


    "iPC injection significantly increases the retention rate of stem cells and exosomes, reduces the immune response, and promotes myocardial infarction in mice and rats.


    In further translational research, the research team used thoracoscopy technology to confirm the feasibility and safety of minimally invasive iPC injection therapy in experimental pigs.


    "IPC injection hydrogel will not cause side effects such as pericardial tamponade and pericarditis.


    "LARIAT refers to percutaneous left atrial appendage ligation.


    It is a commonly used procedure for the clinical treatment of atrial fibrillation-induced stroke and heart failure.


    Reference materials:

    [1]Zhu, D.
    , Li, Z.
    , Huang, K.
    et al.
    Minimallyinvasive delivery of therapeutic agents by hydrogel injection into thepericardial cavity for cardiac repair.
    Nat Commun 12, 1412(2021).

    Professor Cheng Ke’s team researched and reported a new method of minimally invasive “injection” of heart patches.

    Heart disease seriously threatens the lives of patients.
    Existing methods such as intravenous injection, coronary artery injection, myocardial injection, and myocardial patch are used to deliver stem cells to treat damaged myocardium.
    There are disadvantages such as low retention rate, large trauma and high cost of thoracotomy.

    The team of Professor Cheng Ke from North Carolina State University and the University of North Carolina at Chapel Hill reported on a new method of minimally invasive "injection" of heart patches.
    This method injects a hydrogel carrying stem cells or exosomes into the pericardial cavity, and uses the pericardial cavity as a natural hydrogel shaping "mold" to form a uniform repair patch on the surface of the heart.
    Related research results were recently published in "Nature Communications" magazine.
    Professor Cheng Ke is the corresponding author of the article.
    Postdoctoral researchers Zhu Dashuai and Li Zhenhua (currently at the School of Pharmacy of Guangzhou Medical University) are the co-first authors of the article.

    Cell and exosomal treatments provide promising regenerative medicine solutions for repairing damaged myocardium.
    How to directly deliver these therapeutics to the injured area and improve the delivery efficiency is an important challenge for stem cells and exosomes to treat cardiomyopathy.

    "The heart patch is an effective method, but the implantation of the heart patch generally requires open thoracic surgery, and the trauma is serious.
    We seek a safe and effective method that can be implemented minimally.
    " North Carolina State University-North Cheng Ke, Randall B.
    Terry Jr.
    Distinguished Chair Professor of Regenerative Medicine in the Joint Biomedical Engineering Department of the University of California, Chapel Hill, introduced.

    The pericardial cavity is a space between the pericardium and the heart, which is filled with pericardial fluid to provide protection and lubrication for the heart.
    Using the pericardial cavity as a natural mold, using hydrogel to load stem cells and exosomes, through intrapericardial injection, the research team successfully implanted a "heart patch" in the area of ​​myocardial infarction, achieving an "in-situ" mold .

    "We call this delivery method intraPeriCardial injection, that is, iPC injection," Professor Cheng Ke said.
    "iPC injection significantly increases the retention rate of stem cells and exosomes, reduces the immune response, and promotes myocardial infarction in mice and rats.
    Repair of myocardium and improve heart function.
    "

    In further translational research, the research team used thoracoscopy technology to confirm the feasibility and safety of minimally invasive iPC injection therapy in experimental pigs.
    "IPC injection hydrogel will not cause side effects such as pericardial tamponade and pericarditis.
    More importantly, iPC injection is expected to be implemented in clinical patients through a completely minimally invasive way.
    "

    "LARIAT refers to percutaneous left atrial appendage ligation.
    It is a commonly used procedure for the clinical treatment of atrial fibrillation-induced stroke and heart failure.
    For reference, the introduction of intrapericardial catheters during this operation can be easily completed by clinicians iPC injection.
    And these series of operations only require local anesthesia, which fully demonstrates the superiority of iPC injection.
    " said co-author Joe Rossi, associate professor of cardiology at the University of North Carolina at Chapel Hill.
    (Biological Exploration)

    Reference materials:

    [1]Zhu, D.
    , Li, Z.
    , Huang, K.
    et al.
    Minimallyinvasive delivery of therapeutic agents by hydrogel injection into thepericardial cavity for cardiac repair.
    Nat Commun 12, 1412(2021).

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.